MNK

404 Not Found

Not Found

The requested URL /marketdata/market_data_widget/MNK was not found on this server.


Apache/2.2.22 (Ubuntu) Server at api.comtex.com Port 80

Related News

February 20, 2018

SmarTrend identified a Downtrend for Mallinckrodt (NYSE:MNK) on October 13th, 2017 at $33.96. In approximately 4 months, Mallinckrodt has returned 50.53% as of today's recent price of $16.80.

Mallinckrodt...

February 12, 2018

SmarTrend identified a Downtrend for Mallinckrodt (NYSE:MNK) on October 13th, 2017 at $33.96. In approximately 4 months, Mallinckrodt has returned 51.62% as of today's recent price of $16.43.

In the past 52...

February 12, 2018

Below are the three companies in the Pharmaceuticals industry with the lowest enterprise value to EBITDA (EV/EBITDA) ratios. EV/EBITDA is an important metric used in valuing comparable companies. It is capital structure neutral and generally...

February 8, 2018

Below are the three companies in the Pharmaceuticals industry with the lowest current ratios. Current ratio is useful to get an idea of how quickly a company can repay its short-term liabilities with its short-term assets. The higher the...

February 7, 2018

Below are the three companies in the Pharmaceuticals industry with the highest free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.

Mallinckrodt ranks highest with a...

February 5, 2018

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $16.89 to a high of $17.45. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $16.98 on volume of...

February 3, 2018

SmarTrend identified a Downtrend for Mallinckrodt (NYSE:MNK) on October 13th, 2017 at $33.96. In approximately 4 months, Mallinckrodt has returned 49.18% as of today's recent price of $17.26.

Mallinckrodt...

January 28, 2018

Below are the three companies in the Pharmaceuticals industry with the highest earnings yields. Earnings yield is useful to compare the relative benefit of owning a stock vs. owning other yield assets such as bonds. If the earnings yield is...

January 26, 2018

SmarTrend identified a Downtrend for Mallinckrodt (NYSE:MNK) on October 13th, 2017 at $33.96. In approximately 4 months, Mallinckrodt has returned 36.98% as of today's recent price of $21.40.

Over the past...

January 23, 2018

Below are the three companies in the Pharmaceuticals industry with the lowest price to sales per share ratios. Often companies with the lowest ratio present the greatest value to investors.

Endo Internation ranks lowest with a a price to...